Evommune, Inc.

EVMN XNYS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

710M

Short interest (May 15)

8.6%

Net Short (Jun 03 ): 0.1%

Borrow Fee

1.27%

↓ 64.4%

Available Shares

400K

↓ 30.3%

Price Chart

Company Overview

Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.

Company Info

Exchange: NYSE

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0002044725

Asset Type: CS

Market Data

Market Cap: $713,884,133

Employees: 48

Status: Active

Short Interest

Current Borrow Fee 1.27%

Range: 1.27% - 1.34%

Available Shares 400K

Range: 150K - 500K

Recent Changes

Fee Change: ↓ 3.1%

Available Change: ↓ 25.9%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime